Suppr超能文献

在来自不同来源的离体心脏制剂中筛选正性肌力药物。

Screening of positive inotropic agents in isolated cardiac preparations from different sources.

作者信息

Böhm M, Diet F, Pieske B, Erdmann E

机构信息

Medizinische Klinik I Universität München, Klinikum Grosshadern, FRG.

出版信息

J Pharmacol Methods. 1989 Mar;21(1):33-44. doi: 10.1016/0160-5402(89)90020-x.

Abstract

The present study was designed to elucidate whether or not the positive inotropic effects of isoprenaline, milrinone, and DPI 201-106 in myocardial tissue from various sources reveal reliable results for the failing human heart. Therefore, in vitro positive inotropic responses were studied in human papillary muscle strips from patients with moderate heart failure (NNYHA II-III), human atrial trabeculae (HAT), isolated papillary muscles from Wistar-Kyoto rats (WK), and from spontaneously hypertensive rats (SHR). Results were compared with the effects of the compounds in papillary muscle strips from patients with severe heart failure (NYHA IV). In NYHA IV, positive inotropic responses were smaller for isoprenaline and milrinone than in NYHA II-III. The response to DPI 201-106 was more pronounced. In HAT, the effects of isoprenaline and milrinone were greater than in NYHA IV. The positive inotropic effect of DPI 201-106 was similar. In SHR, only the positive inotropic effect of isoprenaline was smaller than in WK. The effects of DPI 201-106 and milrinone did not differ. These data show that inotropic responses in NYHA II-III, HAT, WK, and SHR differ from the severely failing myocardium. It is concluded that new positive inotropic agents should be screened in human myocardial tissue from patients with heart failure, as experimental results from other sources may be irrelevant in this respect.

摘要

本研究旨在阐明异丙肾上腺素、米力农和DPI 201 - 106对不同来源心肌组织的正性肌力作用,对于衰竭的人类心脏而言,是否能得出可靠结果。因此,对中度心力衰竭患者(纽约心脏协会II - III级)的人乳头肌条、人房小梁(HAT)、Wistar - Kyoto大鼠(WK)和自发性高血压大鼠(SHR)的离体乳头肌进行了体外正性肌力反应研究。将结果与这些化合物对重度心力衰竭患者(纽约心脏协会IV级)乳头肌条的作用进行比较。在纽约心脏协会IV级患者中,异丙肾上腺素和米力农的正性肌力反应比纽约心脏协会II - III级患者小。对DPI 201 - 106的反应更明显。在HAT中,异丙肾上腺素和米力农的作用大于纽约心脏协会IV级患者。DPI 201 - 106的正性肌力作用相似。在SHR中,只有异丙肾上腺素的正性肌力作用比WK小。DPI 201 - 106和米力农的作用没有差异。这些数据表明,纽约心脏协会II - III级、HAT、WK和SHR中的正性肌力反应与重度衰竭心肌不同。得出的结论是,新型正性肌力药物应在心力衰竭患者的人心肌组织中进行筛选,因为其他来源的实验结果在这方面可能无关紧要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验